Global Inhalation Anesthesia Market Professional Survey Report 2019
Inhalation anesthetics are used to induce and maintain general anesthesia while performing surgical procedures. Inhalation anesthetic agents are administered through masks or tracheal tubes. These agents get perfused into blood though alveoli and transported to central nervous system where these induce anesthesia.
Inhalation anesthesia has an advantage over other intravenous agents and is considered safer by surgeons. Rising adoption of these drugs in major markets such as U.S., Europe, and Japan is expected to drive revenue growth.
The global Inhalation Anesthesia market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Inhalation Anesthesia volume and value at global level, regional level and company level. From a global perspective, this report represents overall Inhalation Anesthesia market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Inhalation Anesthesia in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Inhalation Anesthesia manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AbbVie Inc.
Baxter
Piramal Enterprises Limited
Halocarbon Products Corporation
Hikma Pharmaceuticals PLC
Lunan Pharmaceutical Group Co.Ltd.
Jiangsu Hengrui Medicine Co. Ltd.
Fresenius Kabi Ag
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Sevoflurane
Desflurane
Isoflurane
Segment by Application
Induction
Maintenance
Inhalation anesthesia has an advantage over other intravenous agents and is considered safer by surgeons. Rising adoption of these drugs in major markets such as U.S., Europe, and Japan is expected to drive revenue growth.
The global Inhalation Anesthesia market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Inhalation Anesthesia volume and value at global level, regional level and company level. From a global perspective, this report represents overall Inhalation Anesthesia market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Inhalation Anesthesia in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Inhalation Anesthesia manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AbbVie Inc.
Baxter
Piramal Enterprises Limited
Halocarbon Products Corporation
Hikma Pharmaceuticals PLC
Lunan Pharmaceutical Group Co.Ltd.
Jiangsu Hengrui Medicine Co. Ltd.
Fresenius Kabi Ag
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Sevoflurane
Desflurane
Isoflurane
Segment by Application
Induction
Maintenance
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
